PubMed Health⌕ Search

Biomedical subjects

Xi-hong Li

Publications and source records attributed to Xi-hong Li.

2 recordsLinked to original sources

[Genetic study on 27 children with beta-thalassemia major and their parents in Sichuan area].

OBJECTIVE: This genetic analysis on 27 children with beta-thalassemia major and their parents was performed in an attempt to elucidate the characteristics of gene mutations, and to improve the early diagnosis and prevention of this disease in Sichuan area. METHODS: The hematologic studies of beta-thalassemia included the osmotic fragility of erythrocyte determined by brine osmosis method, the HbF qualitatively determined by one minute anti-alkaline method, the HbA2 assayed by acetyl-cellulose membrane electrophoresis and eluate photometric method, and the total hemoglobin measured by the ferric-cynade method. DNA was extracted from peripheral white blood cell with standard method (phenol-chloroform extract). Multiple allele specific polymerase chain reaction (MASPCR) was used for targeted DNA amplification and gene mutation analysis. RESULTS: It was found that the most common mutants in Sichuan area were CD17 (A-->T), CD41-42 (-TTCT) and IVS II -654 (C-->T). Their percentages were 43.64%, 36.36% and 14.54%, respectively. CONCLUSION: MASPCR method is a simple, effective and inexpensive method for genetic diagnosis of beta-thalassemia major. We identified 3 most common mutants in Sichuan by using MASPCR.

Adolescent↗

[Preliminary analysis on human telomerase reverse transcriptase gene expression in acute leukemia].

OBJECTIVE: To explore the relationship between gene expression of human telomerase reverse transcriptase (hTERT) and its clinical characteristics in leukemia. METHODS: The protocol of RT-PCR was used to detect the hTERTmRNA expressing levels in peripheral blood samples from leukemic patients under primary treatment(n=42), in complete remission(n=21), with recurrent leukemia (n=4); and from normal subjects (n=5), respectively. RESULTS: The positive percentage of hTERTmRNA expression was 73.81% for the primary treatment cases, and 19.05% for the complete remission cases. All of the recurrent cases gave positive results. One of the normal controls presented low level of hTERTmRNA expression. The expressing level of hTERTmRNA in primary treatment cases was 0.64+/-0.21, in complete remission leukemia 0.31+/-0.16, in recurrent cases 0.84+/-0.09, and in normal controls 0.10. CONCLUSION: The activation of telomerase may be an essential factor in the development of leukemia and usually be the late event in its progression. As an indicator of leukemia cell, the detection of hTERT mRNA may be used in clinical analysis, disease monitoring and prognosis judgement.

Acute Disease↗